Jaber 1996.

Study characteristics
Methods	Evaluation of a pharmaceutical care model on diabetes management Patient RCT, conducted in a university‐affiliated internal medicine outpatient clinic, USA Two arms: 1. Control (control arm) and 2. Intervention (intervention arm)
Participants	Control arm N: 22 Intervention arm N: 23 Diabetes type: type 2 Mean age: 62.4 ± 12.2 % Male: 30.8 Longest follow‐up: 4 months
Interventions	Control arm: None Intervention arm: 1) Case management 2) Team changes 3) Patient education 4) Promotion of self‐management
Outcomes	1) HbA1c, mean % (SD) Control arm: pre 12.2 (3.5), post 12.1 (3.7) Intervention arm: pre 11.5 (2.9), post 9.2 (2.1) 2) Harms (hypoglycaemic reactions), N (%) Control arm: pre NR (NR), post 2 (9) Intervention arm: pre NR (NR), post 17 (100)
Funding source	This work was supported by a grant from the Diabetes Research and Education Foundation and Upjohn
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Information not available.
Allocation concealment (selection bias)	Unclear risk	Information not available.
Patient's baseline characteristics (selection bias)	Low risk	Information not available.
Patient's baseline outcomes (selection bias)	Low risk	Information not available.
Incomplete outcome data (attrition bias)	High risk	Information not available.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Information not available.
Selective reporting (reporting bias)	Low risk	Information not available.
Risk of contamination (other bias)	Unclear risk	Information not available.
Other bias	Unclear risk	Information not available.